|
|
|
| |
|
|
| |
The latest Biotechnology news from AZoNetwork |
|
|
|
 | | |
 Advancing NAMs Together: An Interactive Exchange
Join colleagues spanning research and development for a unique, virtual event discussing New Approach Methodologies where every attendee will be able to participate in a facilitated series of focused conversations for a one-of-a-kind opportunity to network and directly compare experiences and viewpoints.
| |
|
|
| | | | |  In animal models, the flexible implant captured local metabolic warning signs before selected systemic measurements and used them to guide earlier resuscitation. | | | | |  Bio-based furan polyamide dressings effectively direct antibiotic release, offering a sustainable solution for early bacterial control in wounds. | | | | |  Researchers developed a microneedle electrochemiluminescence device that measured cardiac troponins in interstitial fluid at 30-minute intervals and detected cTnI down to 21.3 fg/mL in artificial interstitial fluid. In 15 rats and 1 pig, researchers recorded biomarker trends broadly consistent with serum ELISA results, although the wired, single-target prototype has not been tested in humans. | | | | |  Traumatic injuries, whether on a battlefield or in a car accident, often involve damaged blood vessels that require immediate repair. | | | | |  Nature is beautiful, powerful and essential. But nature is not always gentle. The same biological world that gives rise to forests, coral reefs and human life also produces infections, cancer, genetic disease, crop blights and toxins. | | | | |  Red blood cells serve as the foundation for nanocarriers that show promise in a new study as effective and efficient vehicles for gene therapy, tumor targeting and other medical treatments. | | | | |  Researchers at the UC Davis School of Medicine have identified a naturally occurring metabolite that repairs gut damage caused by HIV infection and significantly improves the effectiveness of antiretroviral therapy (ART) in the nonhuman primate model of HIV/AIDS. | |
|
|
|  | | | How would you rate today's newsletter?
| |
|
|
|
|
|
|
|
